Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway

Oncogene

Volumn 22, Issue 39, 2003, Pages 7998-8011

  Stoica, Gerald E ^a   Franke, Thomas F ^b   Moroni, Maria ^a   Mueller, Susette ^a   Morgan, Elisha ^c   Iann, Mary C ^c   Winder, Abigail D ^c   Reiter, Ronald ^a   Wellstein, Anton ^a   Martin, Mary Beth ^a   Stoica, Adriana ^a,c,d  

^a GEORGETOWN UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Akt; ErbB2; Estradiol; Estrogen receptor

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE ERBB2; PROTEIN TYROSINE KINASE; TAMOXIFEN; UNCLASSIFIED DRUG; WORTMANNIN; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; AKT1 PROTEIN, HUMAN; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MORPHOLINE DERIVATIVE; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CELL ANCHORAGE; CELL CYCLE; CELL GROWTH; CELL MEMBRANE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ESTROGEN ACTIVITY; ESTROGEN BINDING; GENE ACTIVITY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; SCATCHARD PLOT; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANTIBODIES; BREAST NEOPLASMS; CELL DIVISION; CELL MEMBRANE; CHROMONES; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; HUMANS; MORPHOLINES; MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0345549481     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206769     Document Type: Article

References (91)

1. Ahmed NN, Franke TF, Bellacosa A, Datta K, Gonzalez-Portal ME, Taguchi T, Testa JR and Tsichlis PN. (1993). Oncogene, 8, 1957-1963.
2. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P and Hemmings BA. (1996). EMBO J., 15, 6541-6551.
3. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP and Kraus MH. (1995). Oncogene, 10, 1813-1821.
4. Alroy I and Yarden Y. (1997). FEBS Lett., 410, 83-86 (review).
5. Andjelkovic M, Jakubowicz T, Cron P, Ming XF, Han JW and Hemmings BA. (1996). Proc. Natl. Acad. Sci. USA, 93, 5699-5704.
6. Arteaga CL, Coronado E and Osborne CK. (1988). Mol. Endocrinol., 2, 1064-1069.
7. Auricchio F, Di Domenico M, Migliaccio A, Castoria G and Bilancio A. (1995). Cell Growth Differ., 6, 105-113.
8. Bacus SS, Chin D, Yarden Y, Zelnick CR and Stern DF. (1996). Am. J. Pathol., 148, 549-558.
9. Beato M, Herrlich P and Schutz G. (1995). Cell, 83, 851-857 (review).
10. Berry M, Metzger D and Chambon P. (1990). EMBO J., 9, 2811-2818.
11. Berthois Y, Katzenellenbogen JA and Katzenellenbogen BS. (1986). Proc. Natl. Acad. Sci. USA, 83, 2496-2500.
12. Borg A, Baldetorp B, Ferno M, Killander D, Olsson H, Ryden S and Sigurdsson H. (1994). Cancer Lett., 81, 137-144.
13. Burgering BM and Coffer PJ. (1995). Nature, 376, 599-602.
14. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S and Nakshatri H. (2001). J. Biol. Chem., 276, 9817-9824.
15. Carraway III KL and Cantley LC. (1994). Cell, 78, 5-8 (review).
16. Carraway III KL, Soltoff SP, Diamonti AJ and Cantley LC. (1995). J. Biol. Chem., 270, 7111-7116.
17. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV and Auricchio F. (2001). EMBO J., 20, 6050-6059.
18. Craft N, Shostak Y, Carey M and Sawyers CL. (1999). Nat. Med., 5, 280-285.
19. Dauvois S, White R and Parker MG. (1993). J. Cell Sci., 106 (Part 4), 1377-1388.
20. Davis RJ. (1993). J. Biol. Chem., 268, 14553-14556 (review).
21. Dickson RB and Lippman ME. (1987). Endocr. Rev., 8, 29-43 (review).
22. Dickson RB and Lippman ME. (1995). Endocr. Rev., 16, 559-589 (review).
23. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN. (1995). Cell, 81, 727-736.
24. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC and Martin MB. (1994). J. Biol. Chem., 269, 16896-16901.
25. Guiochon-Mantel A, Delabre K, Lescop P and Milgrom E. (1996). J. Steroid Biochem. Mol. Biol., 56 (1-6 Spec No), 3-9 (review).
26. Heath JP and Holifield BF. (1991). Cell Motil. Cytoskel., 18, 245-257 (review).
27. Hellyer NJ, Kim MS and Koland JG. (2001). J. Biol. Chem., 276, 42153-42161.
28. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A and Shimohama S. (2000). J. Neurosci. Res., 60, 321-327.
29. Hynes NE and Stern DF. (1994). Biochim. Biophys. Acta., 1198, 165-184 (review).
30. Johnston SR. (1997). Anticancer Drugs, 8, 911-930 (review).
31. Kato S. (2001). Breast Cancer, 8, 3-9 (review).
32. Kato S, Kitamoto T, Masuhiro Y and Yanagisawa J. (1998). Oncology, 55 (Suppl. 1), 5-10 (review).
33. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME and McInerney EM. (1997). Breast Cancer Res. Treat., 44, 23-38 (review).
34. Kelly MJ and Levin ER. (2001). Trends Endocrinol. Metab., 12, 152-156 (review).
35. Keshamouni VG, Mattingly RR and Reddy KB. (2002). J. Biol. Chem., 277, 22558-22565.
36. Kim HH, Sierke SL and Koland JG. (1994). J. Biol. Chem., 269, 24747-24755.
37. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R and Dickson RB. (1987). Cell, 48, 417-428.
38. Leitzel K, Teramoto Y, Konrad K, Chinchilli VM, Volas G, Grossberg H, Harvey H, Demers L and Lipton A. (1995). J. Clin. Oncol., 13, 1129-1135.
39. Liu W, Li J and Roth RA. (1999). Biochem. Biophys. Res. Commun., 261, 897-903.
40. Lobenhofer EK, Huper G, Iglehart JD and Marks JR. (2000). Cell Growth Differ., 11, 99-110.
41. Mangelsdorf DJ and Evans RM. (1995). Cell, 83, 841-850 (review).
42. Marquez DC and Pietras RJ. (2001). Oncogene, 20, 5420-5430.
43. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE and Stoica A. (2000). Endocrinology, 141, 4503-4511.
44. McDonnell DP, Clemm DL, Hermann T, Goldman ME and Pike JW. (1995). Mol. Endocrinol., 9, 659-669.
45. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB and Kern FG. (1993). Cancer Res., 53, 2168-2177.
46. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E and Auricchio F. (1996). EMBO J., 15, 1292-1300.
47. Molloy CA, May FE and Westley BR. (2000). J. Biol. Chem., 275, 12565-12571.
48. Muthuswamy SK, Gilman M and Brugge JS. (1999). Mol. Cell. Biol., 19, 6845-6857.
49. Nemere I and Farach-Carson MC. (1998). Biochem. Biophys. Res. Commun., 248, 443-449 (review).
50. Nicholson S, Wright C, Sainsbury JR, Halcrow P, Kelly P, Angus B, Farndon JR and Harris AL. (1990). J. Steroid Biochem. Mol. Biol., 37, 811-814.
51. Normanno N and Ciardiello F. (1997. J. Mammary Gland Biol. Neoplasia, 2, 143-151.
52. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ. (1995). Oncogene, 10, 2435-2446.
53. Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M and Yarden Y. (1996). EMBO J., 15, 2452-2467.
54. Prigent SA and Gullick WJ. (1994). EMBO J., 13, 2831-2841.
55. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M and Copeland NG, Jenkins NA and Witte ON. (1993). Science, 261, 358-361.
56. Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A and Osborne CK. (1992). Cancer Res., 52, 3636-3641.
57. Reddy KB, Yee D, Hilsenbeck SG, Coffey RJ and Osborne CK. (1994). Cell Growth Differ., 5, 1275-1282.
58. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongkol M, Puente M and Martin MB. (1988). Mol. Endocrinol., 2, 1157-1162.
59. Salomon DS and Kidwell WR. (1988). Cancer Treat Res., 40, 363-389 (review).
60. Salomon DS, Normanno N, Ciardiello F, Brandt R, Shoyab M and Todaro GJ. (1995). Breast Cancer Res. Treat., 33, 103-114 (review).
61. Salomon DS, Perroteau I, Kidwell WR, Tam J and Derynck R. (1987). J. Cell Physiol., 130, 397-409.
62. Sapino A, Pietribiasi F, Bussolati G and Marchisio PC. (1986). Cancer Res., 46, 2526-2531.
63. Scatchard G. (1949). Ann. NY Acad. Sci. USA, 51, 209-216.
64. Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N and Lupu R. (1996). Oncogene, 12, 1679-1687.
65. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW and Liao JK. (2000). Nature, 407, 538-541.
66. Soltoff SP, Carraway III KL, Prigent SA, Gullick WG and Cantley LC. (1994). Mol. Cell. Biol., 14, 3550-3558.
67. Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R and Santen RJ. (2002). Mol. Endocrinol., 16, 116-127.
68. Sporn MB and Roberts AB. (1985). Nature, 313, 745-747 (review).
69. Stancovski I, Hurwitz E, Leitner O, Ullrich A, Yarden Y and Sela M. (1991). Proc. Natl. Acad. Sci. USA, 88, 8691-8695.
70. Stoica A, Saceda M, Doraiswamy VL, Coleman C and Martin MB. (2000a). J. Endocrinol., 165, 371-378.
71. Stoica A, Saceda M, Fakhro A, Joyner M and Martin MB. (2000b). J. Cell Biochem., 76, 605-614.
72. Stoica A, Katzenellenbogen BS and Martin MB. (2000c). Mol. Endocrinol., 14, 545-553.
73. Stoica EG, Franke TF, Wellstein A, Czubayko F, List HJ, Reiter R, Morgan E, Martin MB and Stoica A. (2003a). Mol. Endocrinol., 17, 818-830.
74. Stoica EG, Franke TF, Wellstein A, Morgan E, Czubayko F, List HJ, Reiter R, Martin MB and Stoica A. (2003b). Oncogene, 22, 2073-2087.
75. Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D and Johnson DH. (2001). Cancer, 92, 2639-2647.
76. Tandon AK, Clark GM, Chamness GC, Ullrich A and McGuire WL. (1989). J. Clin. Oncol., 7, 1120-1128.
77. Tsai MJ and O'Malley BW. (1994). Annu. Rev. Biochem., 63, 451-486 (review).
78. van der Geer P, Hunter T and Lindberg RA. (1994). Annu. Rev. Cell Biol., 10, 251-337 (review).
79. Vasudevan N, Kow LM and Pfaff DW. (2001). Proc. Natl. Acad. Sci. USA, 98, 12267-12271.
80. Vignon F, Bouton MM and Rochefort H. (1987). Biochem. Biophys. Res. Commun., 146, 1502-1508.
81. Vindelov LL, Christensen IJ and Nissen NI. (1983). Cytometry, 3, 323-327.
82. Waterman H, Alroy I, Strano S, Seger R and Yarden Y. (1999). EMBO J., 18, 3348-3358.
83. Watson CS and Gametchu B. (1999). Proc. Soc. Exp. Biol. Med., 220, 9-19 (review).
84. Weigel NL. (1996). Biochem. J., 319 (Part 3), 657-667 (review).
85. Wellstein A, Fang WJ, Khatri A, Lu Y, Swain SS, Dickson RB, Sasse J, Riegel AT and Lippman ME. (1992). J. Biol. Chem., 267, 2582-2587.
86. Wellstein A, Lupu R, Zugmaier G, Flamm SL, Cheville AL, Delli Bovi P, Basilico C, Lippman ME and Kern FG. (1990). Cell Growth Differ., 1, 63-71.
87. Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH and Hung MC. (2000). Cancer Res., 60, 6841-6845.
88. Wosikowski K, Schuurhuis D, Kops GJ, Saceda M and Bates SE. (1997). Clin. Cancer Res., 3 (12 Partt 1), 2405-2414.
89. Wright C, Prasad K and Lennard TJ. (1992). J. Clin. Pathol., 45, 459-460.
90. Zeillinger R, Kury F, Czerwenka K, Kubista E, Sliutz G, Knogler W, Huber J, Zielinski C, Reiner G, Jakesz R, Staffen A, Reiner A, Wrba F and Spona Y. (1989). Oncogene, 4, 109-114.
91. Zhang K, Sun J, Liu N, Wen D, Chang D, Thomason A and Yoshinaga SK. (1996). J. Biol. Chem., 271, 3884-3890.